Intellia Therapeutics FY 2020: revenue $58.0M; diluted EPS −$2.40

Key figures from this report

These are the numbers Intellia Therapeutics reported for the year ended Dec 31, 2020, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.

1. Revenue$58.0MNo year-earlier figure tagged10-K income statement, on EDGAR
2. Net income−$134.2MNo year-earlier figure tagged10-K income statement, on EDGAR
3. Diluted EPS−$2.40No year-earlier figure tagged10-K income statement, on EDGAR
4. Cash and cash equivalents$160.0MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-K balance sheet, on EDGAR
5. Cash from operations−$49.9MNo year-earlier figure tagged10-K cash flow statement, on EDGAR

Every year in the financial tables